Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Join SI Premium – FREE
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- Satellos wins FDA clearance for forazapadin in second muscle disease
- Merck's remigromig meets primary endpoint in DME phase 2b/3 trial
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
